AI in Genomics Market Size, Share Global Analysis Report, 2026-2034
REPORT DETAILS
AI in Genomics Market Summary
The global AI in genomics market was valued at USD 1.04 billion in 2025 and is projected to reach USD 21.08 billion by 2034, registering a CAGR of 39.74% during the forecast period. The growth is driven by rising adoption of artificial intelligence in genomic analysis, increasing demand for precision medicine, and growing investments in genomic research programs worldwide.
Market Statistics
Key Takeaways
- Asia Pacific is expected to grow at a CAGR of 41.5% during the forecast period due to growing genomics investments and expanding healthcare infrastructure.
- Software dominated with 50.0% share in 2025 owing to widespread adoption of AI-powered genomic analysis platforms.
- Variant interpretation accounted for the largest application segment with a share of 26.0% in 2025 due to increasing genomic data analysis requirements.
- Hospitals are projected to grow at the fastest CAGR of 40.3% during the forecast period.
- Rising adoption of precision medicine is accelerating the development.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observation
What is AI In Genomics?
AI in genomics refers to the application of artificial intelligence technologies in the analysis, interpretation, and management of genomic data. The technology helps researchers and healthcare providers identify genetic variations, predict disease risks, accelerate drug discovery, and improve precision medicine outcomes.
The value chain includes sequencing technology providers, AI software developers, cloud platform providers, genomic data service companies, healthcare institutions, pharmaceutical companies, research organizations, and end users. Genomic data generated through sequencing platforms is processed using AI algorithms and delivered to researchers and healthcare professionals for clinical and research applications.
Market expansion is supported by increasing genomic sequencing activities, rising healthcare digitization, growth in precision medicine programs, and expanding investments in biotechnology research. Improvements in machine learning algorithms and cloud-based genomic platforms are further contributing to the growth.
Silicon Carbide Market Driver Impact Analysis
The growth is supported by increasing generation of genomic data, growing need for personalization of healthcare solutions, and application of artificial intelligence in life sciences research. Genomic research initiatives are adopted by governments and healthcare entities in order to enhance disease diagnosis and treatment efficacy. Rising usage of AI-enabled analytic platforms is making it easier to analyze genomic data sets.
| Market Driver | Est. CAGR Impact | Geographic Relevance | Impact Timeline |
| Precision medicine adoption | +2.2% | Global | Medium to long term |
| Genomic data expansion | +1.9% | US, Europe, Asia Pacific | Short to medium term |
| AI technology advancement | +1.6% | Global | Medium term |
| Strategic partnerships | +1.2% | Global | Short to medium term |
| Research funding growth | +1.0% | US, China, Japan | Long term |
* Indicative estimates based on market context and analyst judgment. Figures reflect relative driver weight, not additive CAGR contributions. Source: Polaris Market Research Analysis.
AI solutions are increasingly preferred by healthcare companies and research organizations due to their accuracy, scalability, and compliance with regulations. Demand is also rising for integrated platforms capable of managing large genomic datasets across multiple research environments.
Source: Polaris Market Research Analysis
AI In Genomics Market Industry Dynamics
- Rising genomic sequencing activities are increasing demand for AI platforms.
- Market growth is boosted by precision medicine programs.
- Increasing advancements in AI algorithms have improved genomic analysis accuracy.
- Privacy and security issues pose significant threats.
- Drug discovery applications are creating new growth opportunities.
- Growing research investments are expanding commercial adoption.
AI In Genomics Market Drivers, Restraints and Opportunities
How Is Precision Medicine Driving Growth?
Precision medicine is increasing the demand for advanced genomic analysis tools across healthcare and research institutions. AI solutions are used by healthcare providers for disease risk assessment, formulation of personalized treatment strategies, and patient health outcomes improvement. In May 2026, Myriad Genetics introduced Myriad AI, an innovative AI-based program that is intended to improve genetic testing, clinical decision-making support, and personalized healthcare services through enhanced data analytics(Source: investor.myriad.com).Increasing acceptance of genetic testing and therapies based on biomarkers creates significant amounts of genomic data that need advanced analytics.
How Is Genomic Data Expansion Supporting Market Adoption?
The increasing genomic sequencing activity is contributing greatly towards the rise in demand for AI-enabled data analytics systems. Organizations like research labs and healthcare centers have a lot of genomic data that needs to be processed and analyzed. In June 2026, American Society of Human Genetics (ASHG) introduced an AI Initiative program aimed at fostering responsible use of artificial intelligence technology in human genetics and genomics research(Source: www.ashg.org). With the assistance of AI technology, the process of analysis gets faster while it is easier to discover genetic patterns and disease biomarkers.
What Challenges Restrict Growth?
Privacy issues and compliance requirements continue to hinder the development of the market. Genomics includes personal information about patients that needs to be stored and processed through safe systems. The difference in regulation systems between various countries becomes an extra challenge for the technology vendors. Moreover, high costs of integration and lack of qualified specialists become obstacles to adopting genomics for small businesses.
What Opportunities Exist in the AI in Genomics Market?
Rising adoption of regenerative medicine, precision medicine, and use of organoids in research activities is opening up more business opportunities for market players. Advanced applications of artificial intelligence technology are enabling scientists to discover genetic targets and develop more accurate predictions about treatment outcomes and better efficiency in drug discovery process. Commercialization of organoids and increasing multi-omics research are expected to generate more demand for genomics platforms in the coming years. In June 2026, Merck and Protillion Biosciences announced a collaboration on drug discovery using artificial intelligence for up to USD 510 Billion. These trends are likely to support long-term expansion.
Source: Polaris Market Research Analysis
Segment and Regional Leaders at a Glance
According to Polaris Market Research, Asia Pacific leads the AI in Genomics market while North America is the fastest-growing region.
- Dominant Region: North America
- Fastest Growing Region: Asia Pacific
- Largest Technology Segment: Software
- Largest End User Segment: Research Institutes
AI In Genomics Market Segmentation Analysis
The report provides a comprehensive analysis by offering, application, and end user to identify major revenue-generating and high-growth segments.
AI in Genomics Market by Offering
Which Offering Dominated in 2025?
The software segment dominated the market with a share of 50.0% in 2025 owing to increasing adoption of AI-powered genomic analysis platforms across research institutes and healthcare organizations. Software tools assist customers in managing genomic data, streamlining workflow processes, and providing accurate results. Increasing need for genomic analysis is expected to drive segment growth.
Which Offering is Growing Fastest?
The services segment is projected to grow at the fastest CAGR of 40.2% during the forecast period. Growing demand for consulting, implementation, data management, and genomic analysis support services is contributing to segment expansion across research and healthcare environments.
AI in Genomics Market by Application
Which Application Dominated in 2025?
Variant interpretation dominated the market with 26.0% share in 2025 due to increasing use of genomic sequencing in disease diagnosis and precision medicine programs. AI-based technology is aiding the identification of genetic mutations and improving the interpretability of results. Rising genomic testing activities are supporting segment growth.
Which Application is Growing Fastest in the AI in Genomics Market?
Population genomics is projected to grow at the fastest CAGR of 40.8% during the forecast period. Increasing government-funded genomic research programs and expanding national sequencing initiatives are contributing to rapid segment development.
AI in Genomics Market by End User
Which End User Dominated?
Research institutes dominated the market with 34.0% share in 2025 owing to extensive use of genomic analysis technologies in academic and clinical research activities. In June 2026, the University of Hawaiʻi received a USD 12 Billion NIH grant to establish an AI-powered medical research center focused on advancing biomedical innovation(Source: www.ashg.org).Growing investments in genomics research and increasing collaboration with biotechnology companies are supporting segment growth.
Which End User is Growing Fastest?
Hospitals are projected to grow at the fastest CAGR of 40.3% during the forecast period. Growing adoption of precision medicine and increasing integration of genomic testing into clinical workflows are driving segment expansion.
Segment Summary Table
| Segment | Category | 2025 Status | Forecast CAGR | Key Driver |
| Software | Offering | Largest Share | Moderate | Platform adoption |
| Services | Offering | Fastest Growing | High | Implementation demand |
| Variant Interpretation | Application | Largest Share | Moderate | Genomic testing |
| Population Genomics | Application | Fastest Growing | High | Research investments |
| Research Institutes | End User | Largest Share | Moderate | Research funding |
| Hospitals | End User | Fastest Growing | High | Precision medicine |
Source: Polaris Market Research Analysis
Source: Polaris Market Research Analysis
AI In Genomics Market Regional Analysis
Asia Pacific AI in Genomics Market Growth Rate and Forecast
Asia Pacific is expected to grow at a CAGR of 41.5% and is expected to maintain strong growth during the forecast period. China, Japan, India, South Korea, Hong Kong, and Australia are increasing investments in genomic research and healthcare innovation. In December 2025, Gleneagles Hong Kong launched an AI-powered longevity program that uses genomic and clinical data to deliver personalized preventive healthcare(Source: gleneagles.hk).Programs for genome sequencing that receive government backing, along with the expansion of biotech industries are leading to market development in this region.
North America AI in Genomics Market Size and Share
North American region dominated the market with 43.0% share in 2025 due to the presence of advanced healthcare facilities, adoption of genomic technologies, and research funding. The U.S. continues to be the largest contributor owing to genomic research programs and precision medicine programs. Investments made by biotech companies and healthcare organizations have further boosted the growth. For example, Google DeepMind, Google.org, and Wellcome Sanger Institute formed a genomics consortium in June 2026 to develop AI-driven genomics research.
Europe AI in Genomics Market Analysis
Europe had a considerable share of 26.0% in 2025 owing to the rising activities in genomic research and favorable policies in healthcare. The countries investing in genomics medicine and artificial intelligence technologies include Germany, the UK, France, and the Netherlands. Genomics launched Mystra AI in June 2026, which was a genomics platform used to speed up the discovery and validation of drug targets for biotech and pharmaceutical companies. Increasing partnerships between research organizations and biotech companies is expected to drive the growth in the region.
Latin America AI in Genomics Market Size and Share
Latin America is growing at a constant pace due to growing healthcare investments and growing genomic research capabilities. Some of the countries which have been performing well include Brazil, Mexico, and Argentina. Rising awareness regarding precision medicine is contributing to the growth.
Middle East & Africa AI in Genomics Market Size and Share
The Middle East and Africa market is expanding due to growing healthcare modernization initiatives and increasing investments in biotechnology research. Such countries as Saudi Arabia, UAE, Israel, and South Africa have been backing genomic medicine programs as well as innovation projects in the area of healthcare. BGI Genomics introduced its i99 AI platform in September 2025, which was done to improve precision medicine and transform healthcare under Saudi Arabia’s Vision 2030(Source: www.bgi.com).These developments are creating growth opportunities across the region.
Source: Polaris Market Research Analysis
Regulatory Heatmap
| Region/Country | Policy Environment | Key Regulations | Market Implication | Trend |
| US | Favorable | Official program or regulatory framework in Source Log | Supports procurement and validation | Expanding |
| Canada | Neutral | Federal and provincial procurement rules | Requires local buyer qualification | Developing |
| Germany | Favorable | EU framework plus national programs | Supports regulated adoption | Expanding |
| UK | Neutral | UK standards and procurement framework | Creates entry requirements | Stable |
| China | Favorable | Industrial policy and localization rules | Supports scale but raises localization risk | Expanding |
| Japan | Favorable | Technology and healthcare/industrial policy | Supports premium applications | Stable |
| India | Developing | Sector programs and procurement rules | Creates long-term volume upside | Developing |
| Australia | Neutral | Standards and pilot funding frameworks | Supports selective deployments | Developing |
Source: Polaris Market Research Analysis
AI In Genomics Market Competitive Landscape and Key Players
Competition is fragmented among genomic technology providers, artificial intelligence platform developers, cloud computing companies, healthcare analytics firms, and specialized genomics software providers. Market position should be described as Top 3, Top 5, Top 10, regional leader, or niche leader unless a verified share source exists.
The key players for this market include Illumina, NVIDIA, Google DeepMind, Tempus AI, Fabric Genomics, SOPHiA GENETICS, and DNAnexus. These firms are consolidating their dominance through AI model creation, genomic data analysis capacity, collaboration, cloud technology, and precision medicine initiatives. A final analyst review should validate company positioning using annual reports, investor presentations, and recent commercial agreements before publication.
Competitive Positioning Table
| Company | Est. Market Position | Primary Strength | Geographic Focus | In Report |
| Illumina | Top 5 | Genomics ecosystem and sequencing leadership | Global | Yes |
| NVIDIA | Top 10 | AI computing infrastructure | North America and Europe | Yes |
| Google DeepMind | Regional Leader | Advanced AI models | North America and Asia Pacific | Yes |
| Tempus AI | Niche Leader | Precision medicine platform | US and Europe | Yes |
| Fabric Genomics | Top 10 | Clinical genomics interpretation | Global | Yes |
| SOPHiA GENETICS | Top 5 | Healthcare AI analytics | North America and Europe | Yes |
| DNAnexus | Regional Leader | Genomic data management | Global | Yes |
* Estimated market positioning based on revenue scale, geographic reach, and service breadth. Not ranked by precise market share percentage. Source: Polaris Market Research Analysis.
AI In Genomics Market Technology and Innovation Landscape
The technology landscape is defined by the ability of suppliers to convert genomic data into actionable clinical and research insights. Innovation is focused on machine learning algorithms, cloud-based genomic analysis, workflow automation, multi-omics integration, and compliance-ready data management systems. Businesses are spending on scalable computing capabilities as well as analytics capabilities to enhance the speed and precision of genomic analysis.
| Technology | Adoption Stage | Key Development | Market Impact |
| Automation and workflow orchestration | Growing deployment | Expansion of automated genomic analysis platforms | Reduces analysis time |
| Advanced analytics and AI | Early commercial deployment | Development of large-scale genomic AI models | Improves prediction accuracy |
| Compliance documentation | Mainstream adoption | Enhanced genomic data governance frameworks | Supports regulatory compliance |
| Platform integration | Growing deployment | Integration of sequencing and analytics platforms | Expands user adoption |
| Cloud-based genomic infrastructure | Early commercial deployment | Growth of scalable genomic computing environments | Improves accessibility |
| Multi-omics integration | Growing deployment | Combination of genomic, proteomic, and transcriptomic datasets | Enhances research outcomes |
Source: Polaris Market Research Analysis
AI In Genomics Market Buyer Use Cases and Market Entry Barriers
The genomics artificial intelligence market report assists stakeholders in understanding the opportunity, technology trends, competitive landscape, and investment potential.
| Buyer / Investor Type | Primary Use Case | Key Insight Sought | Decision Horizon |
| Corporate strategy teams | Market expansion assessment | Regional and segment attractiveness | 2 to 5 years |
| Private equity and venture investors | Investment screening | Growth potential and commercialization opportunities | 3 to 7 years |
| Procurement leaders | Vendor evaluation | Cost, reliability, and implementation requirements | 1 to 3 years |
| Product leaders | Product roadmap planning | Technology gaps and customer needs | 1 to 3 years |
| Healthcare organizations | Clinical adoption planning | Regulatory compliance and operational efficiency | 3 to 5 years |
| Government agencies | Genomics program development | Healthcare and research impact | 3 to 7 years |
Source: Polaris Market Research Analysis
Entry barriers into the market consist of high computation needs, privacy issues with the genome information, difficult integration procedures, clinical validation needs, and specialized knowledge in both AI and genomics. Entrants must be capable of performing well analytically, have regulatory compliance ability, and form relationships with healthcare and research organizations.
AI In Genomics Market Premium Insights and Forward Outlook
The growth potential seems positive due to the growing trend of precision medicine adoption, increasing genome sequencing, and the use of artificial intelligence in medical research. The demand from customers for technology that provides clinical impact, scalability, and good data security is growing. Long-term growth opportunities are expected to emerge from regenerative medicine, organoid commercialization, multi-omics research, and AI-assisted drug discovery.
Cost Benchmarking Table
| Product | Est. Price Range | Key Cost Driver | Complexity Tier |
| Software Platforms | USD 50,000 to USD 300,000 | Data integration and validation requirements | Mid to High |
| Professional Services | USD 75,000 to USD 500,000 | Custom implementation and consulting | High |
| Variant Interpretation Solutions | USD 25,000 to USD 200,000 | Analytical workflow complexity | Mid |
| Research Institute Deployments | USD 100,000 to USD 1,000,000 | Scale and computational requirements | High |
| Hospital Genomics Platforms | USD 150,000 to USD 1,500,000 | Clinical integration and compliance | High |
| Population Genomics Programs | USD 500,000 to USD 5,000,000 | Dataset size and infrastructure requirements | Very High |
Source: Polaris Market Research Analysis
Key Players
- DNAnexus, Inc.
- Fabric Genomics, Inc.
- Google DeepMind
- IBM Corporation
- Illumina, Inc.
- Microsoft Corporation
- NVIDIA Corporation
- Oracle Corporation
- SAP SE
- SOPHiA GENETICS SA
- Tempus AI, Inc.
- Thermo Fisher Scientific Inc.
AI In Genomics Market Industry Developments
- June 2026: OpenAI’s o3 model helped researchers identify 18 new genetic diagnoses in previously unsolved rare childhood disease cases(Source: openai.com).
- June 2025: Google DeepMind launched AlphaGenome, an AI model that predicts the effects of genetic variations to advance genome research and disease understanding(Source: deepmind.google)
AI In Genomics Market Segmentation
By Offering Outlook (Revenue, USD Billion, 2021–2034)
- Software
- Services
- Cloud Platforms
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Variant Interpretation
- Population Genomics
- Drug Target Discovery
- Clinical Diagnostics
- Precision Medicine
By End User Outlook (Revenue, USD Billion, 2021–2034)
- Research Institutes
- Hospitals
- Biopharmaceutical Companies
- Diagnostic Laboratories
By Regional Outlook (Revenue, USD Billion, 2021-2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
AI In Genomics Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 1.04 Billion |
| Market Size in 2026 | USD 1.45 Billion |
| Revenue Forecast by 2034 | USD 21.08 Billion |
| CAGR | 39.74% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
FAQ's
• The global AI in genomics market was valued at USD 1.04 billion in 2025 and is projected to witness steady growth during the forecast period.
• The global market is forecast to reach USD 21.08 billion by 2034 at a CAGR of 39.74% during 2026-2034.
• Asia Pacific is expected to witness 41.5% CAGR due to growing investments in genomic research and healthcare innovation.
• Software dominated the market with 50.0% share in 2025 owing to increasing deployment of AI-based genomic analysis platforms.
• Major companies operating in the market include Illumina, NVIDIA, Google DeepMind, Tempus AI, SOPHiA GENETICS, and DNAnexus.
• Adoption of precision medicine, increasing genomics data, AI technological developments, and increasing investment in research are among the factors fueling market growth.
• Regenerative medicine, commercialization of organoids, multi-omics, and AI-driven drug discovery is expected to provide substantial growth opportunities.
Download Sample Report of AI in Genomics Market
Please fill out the form to request a customized copy of the research report.
